RESEARCH PAPER
Socioeconomic characteristics, tobacco use, and service utilization by county poverty status among Oklahoma tobacco helpline registrants: A cross-sectional study
More details
Hide details
1
TSET Health Promotion Research
Center, Stephenson Cancer Center,
The University of Oklahoma
Health Campus, Oklahoma City,
United States
2
Department of Biostatistics and
Epidemiology, Hudson College of
Public Health, The University of
Oklahoma Health Campus,
Oklahoma City, United States
3
Department of Family and
Preventive Medicine, The
University of Oklahoma Health
Campus, Oklahoma City, United
States
4
Department of Internal
Medicine, Section of Hematology/
Oncology, Stephenson Cancer
Center, The University of
Oklahoma Health Campus,
Oklahoma City, United States
Submission date: 2026-01-08
Final revision date: 2026-02-19
Acceptance date: 2026-02-22
Publication date: 2026-07-16
Corresponding author
Gaurav Kumar
TSET Health
Promotion Research Center,
Stephenson Cancer Center, The
University of Oklahoma Health
Campus, Oklahoma City,
Oklahoma, United States, 73104
Tob. Prev. Cessation 2026;12(July):41
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Residents of counties with higher poverty levels experience elevated
smoking rates and disproportionate tobacco-related cancer mortality. This study
examined differences in sociodemographic characteristics, tobacco use, and
service utilization among Oklahoma Tobacco Helpline (OTH) registrants across
county poverty designations.
Methods:
In this cross-sectional study, data were analyzed from 33847 adults
registered with the OTH between 1 July 2023 and 30 June 2024. Counties
were classified as persistent poverty (PPC: ≥20% of residents in poverty for
≥30 years), current poverty (CPC: ≥20% of residents in poverty currently
for <30 years), or non-poverty (NPC: <20% of residents in poverty). Group
differences were examined using the chi-squared test and analysis of variance.
Adjusted multinomial logistic regression analyses evaluated associations
between poverty status, tobacco use, and service utilization, controlling for
age, sex/gender, race, education level, household income, health insurance, and
chronic conditions.
Results:
Registrants residing in PPCs and CPCs differed from those in NPCs
in terms of age and race, and they had lower education, income, and greater
Medicaid coverage (all P<0.05). In adjusted models, PPC registrants had higher
odds of smoking >1 pack/day (heavy smoking) (AOR=1.49; 95% CI: 1.30–1.70;
p<0.001) and learning about OTH through personal networks (AOR=1.42;
95% CI: 1.16–1.73; p<0.001) compared with NPCs. Compared with registrants
residing in non-poverty counties (NPCs), CPC registrants had higher odds of
smoking >1 pack/day (AOR=1.39; 95% CI: 1.16–1.65; p<0.001) and learning
about OTH through community/social organizations (AOR=1.77; 95% CI: 1.33–
2.35; p<0.001). Service type and nicotine replacement therapy receipt/duration
were similar across poverty designations.
Conclusions:
PPC and CPC registrants showed greater socioeconomic disadvantage
and nicotine dependence than NPC registrants but had distinct information
pathways. These findings highlight geographically concentrated poverty
as a potential contributor to tobacco-related disparities and suggest that
interventions addressing social and environmental conditions in PPCs may help
enhance cessation engagement and reduce tobacco-related inequities.
ACKNOWLEDGEMENTS
The authors thank the Oklahoma Tobacco Helpline for providing the data
used in this study. The authors also acknowledge the support of the
Stephenson Cancer Center and the TSET Health Promotion Research Center.
CONFLICTS OF INTEREST
The authors have each completed and submitted an ICMJE form for
disclosure of potential conflicts of interest. The authors declare that they
have no competing interests, financial or otherwise, related to the current
work. G. Kumar reports that since the initial planning of the work he
was funded from the American Cancer Society (CHERC-24-1160021-01-
CHERC), the Oklahoma Tobacco Settlement Endowment Trust (TSET) and the
National Cancer Institute (P30CA225520). L.A. Beebe reports that since the
initial planning of the work she was funded from the Tobacco Settlement
Endowment Trust (TSET) of Oklahoma. She is the PI of a TSET contract
through her institution to evaluate their programs, including the Oklahoma
Tobacco Helpline. L.A. Beebe reports that in the past 36 months she received
grants or contracts from the Tobacco Settlement Endowment Trust (TSET)
of Oklahoma. N. Choradia reports that in the past 36 months he received
grants or contracts from the Presbyterian Health Foundation and the Robert
A. Winn Career Development Award. N.M. Machado reports that in the
past 36 months he received grants or contracts from the American Cancer
Society (2025-2027) and the American Association of University Women
(2022-2023). He also received support for attending meetings from the
Society for Research on Nicotine and Tobacco-Europe (SRNT-E) and the
Society for Research on Nicotine and Tobacco (SRNT). He also received the
2023 Early Career Travel Scholarship Award and the 2023 Health Equity
Network, Travel Scholarship Award. He also participated in the American
Heart Association (AHA) as a workgroup member - development of the
Certified Professional by the American Heart Association (CPAHA) -Tobacco
Treatment certification (unpaid). He also had a leadership/fiduciary role in
Society for Research on Nicotine and Tobacco (SRNT). He was a Planning
Committee member; Co-chair, Public Health Track, 2026 Annual SRNT
Meeting (unpaid).
FUNDING
This research was primarily supported by the Oklahoma Tobacco Settlement
Endowment Trust (TSET). Additional support was provided by the National
Cancer Institute (NCI) Cancer Center Support Grant P30CA225520 awarded
to the Stephenson Cancer Center. Additional funding support was provided
by the American Cancer Society through grants PF-24-1198256-01-HOPS to
NMM and CHERC-24-1160021-01-CHERC to DEK and GK.
ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval and informed consent were not required for this study as it
was a secondary analysis of existing data.
DATA AVAILABILITY
Τhe data supporting this research are available from the authors on
reasonable request.
AUTHORS' CONTRIBUTIONS
GK: conceptualization, formal analysis, writing of the original draft, and
writing, reviewing, and editing of the manuscript. LAB: conceptualization,
data curation, supervision, and writing, reviewing, and editing of the
manuscript. DEK: conceptualization, supervision, and writing, reviewing, and
editing of the manuscript. MEO, MPD, RN, NC, LKB and NMM: reviewed and
edited the manuscript. All authors read and approved the final version of the
manuscript.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer-reviewed.
SUPPLEMENTARY FILE DISCLAIMER
The content has been provided by the author(s) and has not been
reviewed, verified, or endorsed by European Publishing. It may not have
undergone peer review. The views, opinions, and recommendations expressed
are solely those of the author(s) and do not necessarily reflect the position of
European Publishing. European Publishing accepts no responsibility or liability
for any consequences arising from the use of, or reliance on, this content.
REFERENCES (36)
1.
Hecht SS. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22(3):143–155.
doi:10.1038/s41568-021-00423-4
2.
Jassem J. Tobacco smoking after diagnosis of cancer: Clinical aspects. Transl Lung Cancer Res. 2019;8(suppl 1):S50–S58. doi:10.21037/tlcr.2019.04.01
3.
Islami F, Marlow EC, Thomson B, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA A Cancer J Clinicians. 2024;74(5):405–432.
doi:10.3322/caac.21858
4.
Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327–338.
doi:10.3978/j.issn.2218-6751.2015.08.04
5.
Jeon J, Holford TR, Levy DT, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065: A comparative modeling approach. Ann Intern Med. 2018;169(10):684–693. doi:10.7326/M18-1250
6.
Redondo-Sánchez D, Petrova D, Rodríguez-Barranco M, et al. Socio-economic inequalities in lung cancer outcomes: An overview of systematic reviews. Cancers (Basel). 2022;14(2):398. doi:10.3390/cancers14020398
7.
Moss JL, Pinto CN, Srinivasan S, Cronin KA, Croyle RT. Persistent poverty and cancer mortality rates: An analysis of county-level poverty designations. Cancer Epidemiology, Biomarkers & Prevention. 2020;29(10):1949–1954.
doi:10.1158/1055-9965.EPI-20-0007
8.
Miller KK, Weber BA. Persistent Poverty Across the Rural-Urban Continuum. RPRC Working Paper No. 03-01. Rural Poverty Research Center; 2003. Accessed
February 22, 2026.
https://ageconsearch.umn.edu/r...
9.
Hamad R, Brown DM, Basu S. The association of county-level socioeconomic factors with individual tobacco and alcohol use: A longitudinal study of U.S. adults. BMC Public Health. 2019;19(1):390.
doi:10.1186/s12889-019-6700-x
10.
Hiscock R, Dobbie F, Bauld L. Smoking cessation and socioeconomic status: An update of existing evidence from a national evaluation of english stop smoking
services. Biomed Res Int. 2015;2015(1):274056.
doi:10.1155/2015/274056
11.
Drope J, Liber AC, Cahn Z, et al. Who’s still smoking? disparities in adult cigarette smoking prevalence in the United States. CA Cancer J Clin. 2018;68(2):106–115. doi:10.3322/caac.21444
12.
Moss JL, Pinto CN, Shen C. Prevalence of cancer risk behaviors by county-level persistent poverty. Cancer Epidemiol. 2025;94:102735. doi:10.1016/j.canep.2024.102735
13.
Bernacchi V, Hirko K, Boakye EA, et al. Lung cancer disparities in rural, persistent poverty counties: A secondary data analysis. BMC Public Health. 2025;25(1):878. doi:10.1186/s12889-025-22134-3
21.
Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72(6):558–569.
doi:10.4097/kja.19087
22.
Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status and smoking: A review. Ann N Y Acad Sci. 2012;1248(1):107–123.
doi:10.1111/j.1749-6632.2011.06202.x
23.
Stone MD, Pierce JP, Dang B, et al. State and sociodemographic trends in US cigarette smoking with future projections. JAMA Netw Open. 2025;8(4):e256834–e256834. doi:10.1001/jamanetworkopen.2025.6834
24.
Colston DC, Simard BJ, Xie Y, et al. The association between quitline characteristics and smoking cessation by educational attainment, income, race/ethnicity, and sex. Int J Environ Res Public Health. 2021;18(6):3297.
doi:10.3390/ijerph18063297
25.
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/gender differences in smoking cessation: A review. Preventive Medicine. 2016;92:135–140. doi:10.1016/j.ypmed.2016.07.013
26.
van Wijk EC, Landais LL, Harting J. Understanding the multitude of barriers that prevent smokers in lower socioeconomic groups from accessing smoking cessation support: A literature review. Preventive Medicine.
2019;123:143–151. doi:10.1016/j.ypmed.2019.03.029
27.
Pourtau L, Martin E, Menvielle G, El Khoury-Lesueur F, Melchior M. To smoke or not to smoke? A qualitative study among young adults. Prev Med Rep. 2019;15:100927. doi:10.1016/j.pmedr.2019.100927
28.
Tobacco Settlement Endowment Trust. Oklahoma Tobacco Helpline FY23 Evaluation Report. Oklahoma Tobacco Settlement Endowment Trust; 2023. Accessed February 22, 2026.
https://oklahoma.gov/content/d...
29.
Beebe LA, Boeckman LM, Klein PG, Saul JE, Gillaspy SR. They came, but will they come back? An observational study of re-enrollment predictors for the
oklahoma tobacco helpline. Am J Health Promot. 2020;34(3):261–268. doi:10.1177/0890117119890789
30.
Hood-Medland EA, Stewart SL, Nguyen H, et al. Health system implementation of a tobacco quitline ereferral. Appl Clin Inform. 2019;10(4):735–742. doi:10.1055/s-0039-1697593
31.
Sedani AE, Frank-Pearce SG, Chen S, et al. Impact of quitline services on tobacco cessation: An application of modern epidemiologic methods. Am J Epidemiol. 2025;194(5):1322–1331. doi:10.1093/aje/kwae292
32.
Alcantara IC, Villaluz N, McAleer K, Valliani I, Ross LW. Commercial tobacco cessation interventions for american indian and alaska native persons living in the united states: A narrative systematic review of effectiveness using a health equity lens. Am J Health Promot. 2025;39(2):330–347. doi:10.1177/08901171241293419
33.
Smith PH, Zhang J, Weinberger AH, Mazure CM, McKee SA. Gender differences in the real-world effectiveness of smoking cessation medications: Findings from the 2010-2011 tobacco use supplement to the current population survey. Drug Alcohol Depend. 2017;178:485–491. doi:10.1016/j.drugalcdep.2017.05.046
34.
Rusk AM, Kanj AN, Murad MH, Hassett LC, Kennedy CC. Smoking cessation interventions in indigenous north americans: A meta-narrative systematic review. Nicotine Tob Res. 2023;25(1):3–11. doi:10.1093/ntr/ntac181
35.
Wang X, Babb S, Xu X, et al. Receipt of cessation treatments among medicaid enrollees trying to quit smoking. Nicotine Tob Res. 2021;23(6):1074–1078.
doi:10.1093/ntr/ntaa213
36.
Colston DC, Cruz JL, Simard BJ, Fleischer NL. A systematic review evaluating disparities in state-run quitline utilization and effectiveness in the U.S. AJPM
Focus. 2023;2(1):100042. doi:10.1016/j.focus.2022.100042